AQUILON PHARMACEUTICALS
Personen
13
Locaties
4
Publicaties
13
Bedrijfsprofiel
Oprichtingsdatum
16 oktober 2013
Laatste Balansjaar
2024
Rechtsvorm
Naamloze vennootschap
Ondernemingstype
Rechtspersoon
Activiteit
72101 - Speur- en ontwikkelingswerk op biotechnologisch gebied
Leeftijd Onderneming
13 jaar
Contactgegevens
Unlock direct contact points, registry address detail, and website links for AQUILON PHARMACEUTICALS.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorische Financiële Gegevens
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Omzet | - | - | - |
| Brutomarge | € 991.768 (+8.1%) | € 917.235 (+103.3%) | € 451.097 (+190.4%) |
| Winst | € -913.660 (+2.5%) | € -936.675 (-22.8%) | € -762.477 (-21.2%) |
| EBITDA | € -470.572 (+5.7%) | € -498.758 (-5.5%) | € -472.735 (+15.7%) |
| Eigen Vermogen | € 1.296.242 (-30.4%) | € 1.863.008 (+144.9%) | € 760.758 (-50.1%) |
| Schulden | € 8.976.765 (+13.6%) | € 7.905.296 (+12.1%) | € 7.053.414 (+47.7%) |
| Totaal Activa | € 10.306.004 (+5.3%) | € 9.784.947 (+25.2%) | € 7.815.276 (+24.1%) |
| Kasmiddelen | € 208.427 (-61.1%) | € 535.282 (-11.3%) | € 603.141 (-41.2%) |
| VTE (FTE) | 9,4 (+2.2%) | 9,2 (+12.2%) | 8,2 (+17.1%) |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for AQUILON PHARMACEUTICALS.
Create Free AccountFinanciële Gezondheid
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
0,1x
(-56.0%)
Quick Ratio
0,1x
(-56.0%)
Solvency
12,6%
(-33.9%)
Debt / Equity
6,9x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountVestigingen & Voetafdruk
Establishment
AdresGeen gegevens beschikbaar
Establishment
AdresGeen gegevens beschikbaar
Establishment
AdresGeen gegevens beschikbaar
Unlock Full Footprint
See every known establishment, linked address, and operating footprint tied to AQUILON PHARMACEUTICALS.
Create Free AccountBedrijfsnetwerk
First-level relations linked directly to AQUILON PHARMACEUTICALS. Unlock second-level relations for deeper graph exploration.
AQUILON PHARMACEUTICALS
Actief
- MAES PHARMCONSULT
Incoming link
Administrator Legal - SAMBRINVEST SPIN-OFF/SPIN-OUT
Incoming link
Administrator Legal - SCALE I
Incoming link
Administrator Legal -
Didier CATALDO
Incoming link
Administrator Natural -
Franck PIETERS
Incoming link
Administrator Natural -
Frank PIETERS
Incoming link
Administrator Natural -
Hassan BENAMEUR
Incoming link
Administrator Natural -
Joseph GHELDERE
Incoming link
Administrator Natural -
Michaël MELLINK
Incoming link
Administrator Natural -
Moshe MANOR
Incoming link
Administrator Natural - P&L Projects
Outgoing link
Participating Interest - SAMBRINVEST SPIN-OFF/SPIN-OUT
Outgoing link
Participating Interest - SCALE I
Outgoing link
Participating Interest -
Elisabeth DE HALLEUX
Incoming link
Administrator Legal Representative -
Gauthier VAN DER ELST
Incoming link
Administrator Legal Representative -
Gauthier VAN DER ELST Gauthier
Incoming link
Administrator Legal Representative -
Micheline Streel
Incoming link
Administrator Legal Representative -
Paul MAES
Incoming link
Administrator Legal Representative -
Thomas Donck
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpPublicaties in het Belgisch Staatsblad
Management & Sleutelfiguren
Unlock linked people, governance roles, and enriched demographic signals associated with AQUILON PHARMACEUTICALS.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account